EAMA
BPMC

EFG Asset Management (Americas)’s Blueprint Medicines BPMC Stock Holding History

EFG Asset Management (Americas)’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,500
Closed -$348K – 139
2023
Q2 		$348K Sell
5,500
-1,216
-18% -$66.1K 0.08% 124
2023
Q1 		$302K Buy
6,716
+789
+13% +$35.5K 0.07% 123
2022
Q4 		$260K Sell
5,927
-357
-6% -$17.1K 0.06% 118
2022
Q3 		$414K Sell
6,284
-403
-6% -$25.9K 0.1% 107
2022
Q2 		$338K Sell
6,687
-1,178
-15% -$69K 0.08% 115
2022
Q1 		$502K Buy
7,865
+1,755
+29% +$126K 0.09% 112
2021
Q4 		$654K Buy
6,110
+121
+2% +$12.7K 0.11% 107
2021
Q3 		$616K Buy
5,989
+1,014
+20% +$94.4K 0.11% 108
2021
Q2 		$438K Buy
4,975
+1,271
+34% +$116K 0.08% 120
2021
Q1 		$360K Buy
3,704
+1,371
+59% +$137K 0.07% 119
2020
Q4 		$262K Sell
2,333
-110
-5% -$11.6K 0.05% 126
2020
Q3 		$226K Buy
+2,443
New +$188K 0.05% 131

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

EFG Asset Management (Americas)'s BPMC Position: Q3 2023 in Review

EFG Asset Management (Americas) sold out of Blueprint Medicines (BPMC) in Q3 2023, closing a stake of 5,500 shares — an estimated $348K sold.

EFG Asset Management (Americas) first reported a position in BPMC in Q3 2020 and held it in 12 quarters. The position peaked at $654K in Q4 2021. 220 funds tracked by Wall St. Rank hold BPMC as of Q3 2023.

  • EFG Asset Management (Americas) reported no remaining Blueprint Medicines position as of Q3 2023 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 5,500 Blueprint Medicines shares in Q3 2023, an estimated $348K.
  • EFG Asset Management (Americas) first reported a position in Blueprint Medicines in Q3 2020 and held it in 12 quarters.
  • EFG Asset Management (Americas)'s Blueprint Medicines position peaked at $654K in Q4 2021.
  • 220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2023.

Based on EFG Asset Management (Americas)'s 13F filing for Q3 2023, filed 9 Nov 2023.